Stakeholders across the entire healthcare chain are looking to incorporate artificial intelligence (AI) into their decision-making process. From early-stage drug discovery to clinical decision support systems, we have seen examples of how AI can impr...
Artificial intelligence (AI) has achieved human-level capabilities and continues to rapidly improve. For the pharmaceutical industry, AI can improve decision-making and transform the quest for better medicines. The keys are investing in data manageme...
The disruption of large protein-protein (PP) interfaces remains a challenge in targeted therapy. Designing drugs that compete with binding partners is daunting, especially when the structure of the protein complex is unknown. To address the problem w...